Commissioning policies

 WMCSU is currently collecting commissioning policies from commissioning organisations in the West Midlands region. In the future, these will be put into a database which will be searchable via our website.

Policies from the West Midlands Specialised Commissioning Team (WMSCT)

Model Commissioning Policies for West Midlands PCTs to review and consider adopting:

Choice
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Experimental and Unproven Treatments
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

In Year Service Developments
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Individual Funding Requests
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Defining the boundaries between NHS and Private Healthcare
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Implementation and funding of guidance produced by NICE
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Patients changing responsible commissioner
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Ongoing access to treatment following the completion of a trial explicitly funded by the Primary Care Trust
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Ongoing access to treatment following the completion of industry sponsored clinical trials or funding
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Ongoing access to treatment following the completion of non-commercially funded clinical trials
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Ongoing access to treatment following a ‘trial of treatment’ which has not been sanctioned by the Primary Care Trust for a treatment
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

Patients Seeking NHS Funded Hospital Treatment in the European Union, European Economic Area or Switzerland
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

The Ethical Framework
Full Policy (.doc)
Equality Impact Assessment (.doc)
Version Control (.pdf)

List of Definitions
Full Policy (.doc)
Version Control (.pdf) 

Regional Treatment Specific Policies - for treatments which are only commissioned by WMSCT:

WM1 - PFO Migraine
WM2 - AIT Renal Transplant
WM3 - Cardiac Extracorporeal Life Support
WM4 - Targeted Therapies for the treatment of Pulmonary Arterial Hypertension
WM5 - Withdrawal of Sitaxsentan
WM6 - Plerixafor Interim Commissioning Policy
WM7 - Stereotactic Radiosurgery for Acoustic Neuroma

Regional Treament Specific Policies - for treatments which may be commissioned either by WMSCT or PCTs depending on the setting:

WM8 - Arrangements for patients affected by withdrawal of use of Palivizumab for prevention of RSV

Regional Treatment Specific Policies - operated by PCTs:

WM9 - Extra Corporeal Photopheresis
WM10 - Siklos - Sickle Cell Anaemia